{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:37:24Z","timestamp":1792643844849,"version":"4.5.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol India"],"published-print":{"date-parts":[[2016]]},"DOI":"10.4103\/0028-3886.181542","type":"journal-article","created":{"date-parts":[[2016,5,4]],"date-time":"2016-05-04T00:41:38Z","timestamp":1462322498000},"page":"405","source":"Crossref","is-referenced-by-count":13,"title":["MG-QoL-15 scores in treated myasthenia gravis: Experience from a university hospital in India"],"prefix":"10.4103","volume":"64","author":[{"given":"ArunB","family":"Taly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhu","family":"Nagappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjib","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivaji","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0028-3886.181542-1","first-page":"299","volume-title":"The World Health Organization's WHOQOL-BREF quality of life assessment: Psychometric properties and results of the international field trial.A report from the WHOQOL group","author":"Skevington","year":"2004","journal-title":"Qual Life Res"},{"key":"key-10.4103\/0028-3886.181542-2","first-page":"492","volume-title":"Once myasthenic, always myasthenic.Observations on the behavior and prognosis of myasthenia gravis in a cohort of 100 patients?","author":"Khadilkar","year":"2014","journal-title":"Neurol India","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3886","issn-type":"print"},{"key":"key-10.4103\/0028-3886.181542-3","first-page":"957","volume-title":"Less is more, or almost as much: A 15-item quality-of-life instrument for myasthenia gravis","author":"Burns","year":"2008","journal-title":"Muscle Nerve"},{"key":"key-10.4103\/0028-3886.181542-4","first-page":"16","volume-title":"Myasthenia gravis: Recommendations for clinical research standards.Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America","author":"Jaretzki","year":"2000","journal-title":"Neurology"},{"key":"key-10.4103\/0028-3886.181542-5","first-page":"445","volume-title":"Standards of measurements in myasthenia gravis","author":"Gajdos","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"key-10.4103\/0028-3886.181542-6","first-page":"5","volume-title":"History of outcome measures for myasthenia gravis","author":"Burns","year":"2010","journal-title":"Muscle Nerve"},{"key":"key-10.4103\/0028-3886.181542-7","first-page":"153","volume-title":"More than meets the eye: The benefits of listening closely to what our patients with myasthenia gravis are telling us","author":"Burns","year":"2012","journal-title":"Muscle Nerve"},{"key":"key-10.4103\/0028-3886.181542-8","first-page":"225","volume-title":"Long-term outcome and quality of life after thymectomy for myasthenia gravis","author":"Busch","year":"1996","journal-title":"Ann Surg"},{"key":"key-10.4103\/0028-3886.181542-9","first-page":"98","volume-title":"The relationship between health, disability and quality of life in myasthenia gravis: Results from an Italian study","author":"Leonardi","year":"2010","journal-title":"J Neurol"},{"key":"key-10.4103\/0028-3886.181542-10","first-page":"571","volume-title":"Factors correlating quality of life in patients with myasthenia gravis","author":"Kulkantrakorn","year":"2010","journal-title":"Neurol Sci"},{"key":"key-10.4103\/0028-3886.181542-11","first-page":"512","volume-title":"Quality of life and well-being of patients with myasthenia gravis","author":"Paul","year":"2001","journal-title":"Muscle Nerve"},{"key":"key-10.4103\/0028-3886.181542-12","first-page":"2058","volume-title":"Correlation between a patient-derived functional questionnaire and abnormal neuromuscular transmission in myasthenia gravis patients","author":"Rostedt","year":"2005","journal-title":"Clin Neurophysiol"},{"key":"key-10.4103\/0028-3886.181542-13","first-page":"394","volume-title":"A trial of mycophenolate mofetil with prednisone as initial immunotherapy in myasthenia gravis","author":"Muscle","year":"2008","journal-title":"Neurology"},{"key":"key-10.4103\/0028-3886.181542-14","first-page":"363","volume-title":"Health-related quality of life in patients with myasthenia gravis and the relationship between patient-oriented assessment and conventional measurements","author":"Padua","year":"2001","journal-title":"Neurol Sci"},{"key":"key-10.4103\/0028-3886.181542-15","first-page":"1167","volume-title":"Quality of life of myasthenia gravis patients","author":"Kulkantrakorn","year":"2010","journal-title":"J Med Assoc Thai"},{"key":"key-10.4103\/0028-3886.181542-16","first-page":"129","volume-title":"Quality of life and life circumstances in German myasthenia gravis patients","author":"Twork","year":"2010","journal-title":"Health Qual Life Outcomes"},{"key":"key-10.4103\/0028-3886.181542-17","first-page":"9","volume-title":"Quality of life and measures of quality of life in patients with neuromuscular disorders","author":"Burns","year":"2012","journal-title":"Muscle Nerve"},{"key":"key-10.4103\/0028-3886.181542-18","first-page":"1051","volume-title":"Construction and validation of a quality of life questionnaire for neuromuscular disease (INQoL)","author":"Vincent","year":"2007","journal-title":"Neurology"},{"key":"key-10.4103\/0028-3886.181542-19","first-page":"114","volume-title":"The myasthenia gravis-specific activities of daily living profile","author":"Muppidi","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"key-10.4103\/0028-3886.181542-20","first-page":"59","volume-title":"Myasthenia gravis outcome measure: Development and validation of a disease-specific self-administered questionnaire","author":"Padua","year":"2002","journal-title":"Neurol Sci"},{"key":"key-10.4103\/0028-3886.181542-21","first-page":"331","volume-title":"Myasthenia gravis self-administered questionnaire: Development of regional domains","author":"Padua","year":"2005","journal-title":"Neurol Sci"},{"key":"key-10.4103\/0028-3886.181542-22","first-page":"947","volume-title":"Disease-specific measure of quality of life for myasthenia gravis","author":"Mullins","year":"2008","journal-title":"Muscle Nerve"},{"key":"key-10.4103\/0028-3886.181542-23","first-page":"219","volume-title":"Mg composite and mg-qol15 study group.Construct and concurrent validation of the MG-QOL15 in the practice setting","author":"Burns","year":"2010","journal-title":"Muscle Nerve"},{"key":"key-10.4103\/0028-3886.181542-24","first-page":"166","volume-title":"The MG-QOL15 Japanese version: Validation and associations with clinical factors","author":"Masuda","year":"2012","journal-title":"Muscle Nerve"},{"key":"key-10.4103\/0028-3886.181542-25","first-page":"1375","volume-title":"Assessment of health-related quality of life in patients with myasthenia gravis in Belgrade (Serbia)","author":"Basta","year":"2012","journal-title":"Neurol Sci"},{"key":"key-10.4103\/0028-3886.181542-26","first-page":"94","volume-title":"Changes in quality of life scores with intravenous immunoglobulin or plasmapheresis in patients with myasthenia gravis","author":"Barnett","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.4103\/0028-3886.181542-27","first-page":"1473","volume-title":"Health-related quality of life in ALS, myasthenia gravis and facioscapulohumeral muscular dystrophy","author":"Winter","year":"2010","journal-title":"J Neurol"},{"key":"key-10.4103\/0028-3886.181542-28","first-page":"1434","volume-title":"The MG Composite: A valid and reliable outcome measure for myasthenia gravis","author":"Burns","year":"2010","journal-title":"Neurology"},{"key":"key-10.4103\/0028-3886.181542-29","first-page":"174","volume-title":"Myasthenia gravis: Sleep quality, quality of life, and disease severity","author":"Martinez-Lapiscina","year":"2012","journal-title":"Muscle Nerve"},{"key":"key-10.4103\/0028-3886.181542-30","first-page":"493","volume-title":"Health-related quality-of-life and treatment targets in myasthenia gravis","author":"Utsugisawa","year":"2014","journal-title":"Muscle Nerve"},{"key":"key-10.4103\/0028-3886.181542-31","first-page":"142","volume-title":"Quality of life in purely ocular myasthenia in Japan","author":"Suzuki","year":"2014","journal-title":"BMC Neurol"},{"key":"key-10.4103\/0028-3886.181542-32","first-page":"14","volume-title":"The MG-QOL15 for following the health-related quality of life of patients with myasthenia gravis","author":"Burns","year":"2011","journal-title":"Muscle Nerve"}],"container-title":["Neurology India"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:22:04Z","timestamp":1786713724000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0028-3886.181542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016]]}},"alternative-id":["181542"],"URL":"https:\/\/doi.org\/10.4103\/0028-3886.181542","relation":{},"ISSN":["0028-3886"],"issn-type":[{"value":"0028-3886","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}